Found: 7
Select item for more details and to access through your institution.
Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.
- Published in:
- Pharmacology Research & Perspectives, 2015, v. 3, n. 3, p. 1, doi. 10.1002/prp2.136
- By:
- Publication type:
- Article
Effect of Atorvastatin Treatment on Isoproterenol-Induced Myocardial Infarction in Rats.
- Published in:
- Pharmacology, 2006, v. 77, n. 1, p. 25, doi. 10.1159/000092308
- By:
- Publication type:
- Article
Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10530-0
- By:
- Publication type:
- Article
Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10530-0
- By:
- Publication type:
- Article
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1084, doi. 10.1111/liv.13634
- By:
- Publication type:
- Article
Hypothalamic leptin action is mediated by histone deacetylase 5.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10782, doi. 10.1038/ncomms10782
- By:
- Publication type:
- Article
The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.
- Published in:
- Nature Communications, 2013, v. 4, n. 6, p. 1968, doi. 10.1038/ncomms2968
- By:
- Publication type:
- Article